NEW YORK & CHICAGO–(BUSINESS WIRE)– #MydCombi–Eyenovia has tapped EVERSANA as exclusive distributor of its MydCombi product for pupil dilation in the U.S., pending the product’s FDA approval.
Author: Business Wire
Aura Biosciences Announces Oversubscribed $80 Million Financing
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the closing of an oversubscribed $80 million…
KalVista Pharmaceuticals Appoints Nancy Stuart to Board of Directors
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)—- $KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors,…
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with …
Bosma Honors Blinded Veterans Association as its 2021 Community Partner
INDIANAPOLIS–(BUSINESS WIRE)–Bosma today announced the Blinded Veterans Association (BVA) has received the organization’s 2021 Community Partner Award. Rooted in more than 100 years of history, Bosma is a nonprofit organization providing training and…
Global Lenses for Myopia Control Market (2020 to 2025) – by Lens Type, Age, Sales Channel, Distribution Channel, Region and Country – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Lenses for Myopia Control Market – Analysis By Lens Type, Contact Lens, Spectacle Lens, Age, Sales Channel, Distribution Channel, Region, Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and For…
NovaBay Pharmaceuticals to Hold 2020 Fourth Quarter and Full Year Conference Call on March 25
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces it will report financial results for the three and 12 months ended December 31, 2020 after market close on Thursday, March 25, 2021 and will hold an inve…
Eyenovia Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Safety of its MAP™ Fixed-Combination Tropicamide-Phenylephrine Product for Mydriasis
NEW YORK–(BUSINESS WIRE)– #Optejet–Eyenovia’s MAP™ fixed-combination pharmaceutical for pupil dilation has been shown to be safe, effective and superior in comparative study.
Lineage to Present at the Benzinga Global Biotech Small Cap Conference on March 24, 2021
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #DryAMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Cull…
MediPrint™ Ophthalmics Announces Successful Completion of Its SIGHT-1 Phase 2a Clinical Study
SAN DIEGO–(BUSINESS WIRE)–MediPrint™ Ophthalmics Announces Successful Completion of Its SIGHT-1 Phase 2a Clinical Study
Visus Therapeutics Announces FDA Acceptance of IND for Presbyopia-Correcting Eye Drop
SEATTLE–(BUSINESS WIRE)–The FDA accepts Visus Therapeutics’ Investigational New Drug Application, allowing the initiation of a Phase 2 study of BRIMOCHOL for presbyopia
Kala Pharmaceuticals Announces Preferred Position for EYSUVIS™ on Cigna
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that Cigna has added E…
Contentsquare Foundation Launches With Mission to Reduce Digital Accessibility Gap
NEW YORK–(BUSINESS WIRE)– #CX–Contentsquare Foundation aims to reduce accessibility gap
Alcon to Host Virtual Capital Markets Day on March 24
GENEVA–(BUSINESS WIRE)–Alcon to Host Virtual Capital Markets Day on March 24
Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Dry Eye Innovation Showcase
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Ocular Therapeutix™ Reports Fourth Quarter and Year End 2020 Financial Results and Business Update
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today r…
H.I.G. Capital Portfolio Company American Vision Partners Continues Strategic Expansion Through Partnership with Southwest Eye Institute
SAN FRANCISCO–(BUSINESS WIRE)– #AmbulatorySurgicalCenters–H.I.G. Capital portfolio company, American Vision Partners entered into a strategic partnership with Southwest Eye Institute, based in El Paso, TX.
Aerie Pharmaceuticals to Participate in the Oppenheimer 31st Annual Virtual Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Aldeyra Therapeutics Reports Full-Year 2020 Financial Results and Recent Business Highlights
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseas…
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)—- $KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors,…